Kody A. Waldstein

Respiratory syncytial virus prevention within reach: the vaccine and monoclonal antibody landscape.

O. Ramilo, A. Mejias, P. Lemey, 2022, The Lancet. Infectious diseases.

Respiratory viruses and the inflammasome: The double-edged sword of inflammation

S. Varga, Kody A. Waldstein, Kody A Waldstein, 2022, PLoS pathogens.

Use of compressed sensing to expedite high-throughput diagnostic testing for COVID-19 and beyond

Weiyu Xu, R. Mudumbai, S. Varga, 2021, medRxiv.

Use of compressed sensing to expedite high-throughput diagnostic testing for COVID-19 and beyond

R. Mudumbai, Myung Cho, S. Varga, 2022, PLoS Comput. Biol..

Current Insights in the Development of Efficacious Vaccines Against RSV

S. Varga, Laura M Stephens, J. Soto, 2020, Frontiers in Immunology.

Prefusion F–Based Polyanhydride Nanovaccine Induces Both Humoral and Cell-Mediated Immunity Resulting in Long-Lasting Protection against Respiratory Syncytial Virus

B. Narasimhan, K. Legge, J. McLellan, 2021, The Journal of Immunology.

Topical Adenosine Inhibits Inflammation and Mucus Production in Viral Acute Rhinosinusitis

S. Varga, S. Tilley, Kody A. Waldstein, 2022, The Laryngoscope.

Nasal virus infection induces asthma exacerbation through B-cell-dependent recruitment of inflammatory monocytes.

Kody A. Waldstein, Xiaoyang Hua, Arman Issimov, 2024, International forum of allergy & rhinology.